T cell receptor–major histocompatibility complex class II complex (TCR–MHC class II complex)

The **T cell receptor–major histocompatibility complex class II complex** is a molecular assembly formed when the T cell receptor (TCR) on CD4+ T lymphocytes specifically recognizes and binds to a peptide antigen presented by the MHC class II molecule on antigen-presenting cells such as dendritic cells, B cells, and macrophages[1][5][7][8]. The TCR is highly variable, enabling the recognition of a vast array of peptide-MHC class II (pMHCII) complexes derived from extracellular proteins. This interaction is central to initiating CD4+ T helper cell activation, differentiation, and the orchestration of adaptive immune responses, including antibody production and recruitment of additional immune cells[1][4][8]. The specificity, affinity, and duration of the TCR–MHC class II binding, together with co-stimulatory signals, determine the quality and magnitude of the T cell response. Failures or aberrations in this molecular interaction are implicated in autoimmunity, immunodeficiency, chronic infection, and immune evasion by tumors[2][4][8]. The TCR–MHC class II complex as a functional unit is the principal node for therapeutic interventions aimed at modulating CD4+ T cell responses in various immunological diseases[4][6][8].

Other names

TCR–MHCII complexT cell receptor/MHC class II complexTCR–peptide–MHC class II complexTCR–pMHCII complex

Inhibition of TCR activation (e.g., calcineurin inhibitors interfering with TCR signaling) Blockade of co-stimulatory signals required for full T cell activation (e.g., abatacept) Modulation of downstream signaling pathways such as calcineurin–NFAT, PKCθ–NF-κB, and mTOR signaling[4][6][8]